Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alveolar Childhood Rhabdomyosarcoma”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Study completedNCT01055314
What this trial is testing

Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal Rhabdomyosarcoma+3 more
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Study completedNCT00003745
What this trial is testing

Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 125
Large-scale testing (Phase 3)UnknownNCT00379457
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

Who this might be right for
Sarcoma
European Paediatric Soft Tissue Sarcoma Study Group 600
Testing effectiveness (Phase 2)Study completedNCT00031915
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00002898
What this trial is testing

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
Societe Internationale d'Oncologie Pediatrique 400
Testing effectiveness (Phase 2)Study completedNCT00331643
What this trial is testing

Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Adult RhabdomyosarcomaAdult Synovial SarcomaAlveolar Childhood Rhabdomyosarcoma+10 more
National Cancer Institute (NCI) 120
Not applicableStudy completedNCT01567046
What this trial is testing

Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas

Who this might be right for
Childhood Alveolar Soft-part SarcomaChildhood AngiosarcomaChildhood Desmoplastic Small Round Cell Tumor+12 more
Children's Oncology Group 70
Large-scale testing (Phase 3)UnknownNCT00334854
What this trial is testing

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
European Paediatric Soft Tissue Sarcoma Study Group 250
Not applicableStudy completedNCT01365962
What this trial is testing

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 60
Very early researchStudy completedNCT00662233
What this trial is testing

Combination Chemotherapy in Treating Patients With Sarcoma

Who this might be right for
Ovarian CancerSarcoma
Mayo Clinic 28
Not applicableStudy completedNCT01496573
What this trial is testing

Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma

Who this might be right for
Alveolar Childhood RhabdomyosarcomaChildhood RhabdomyosarcomaEmbryonal Childhood Rhabdomyosarcoma
Children's Oncology Group 77
Not applicableStudy completedNCT01609803
What this trial is testing

Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma

Who this might be right for
Alveolar Childhood RhabdomyosarcomaEmbryonal Childhood RhabdomyosarcomaPreviously Treated Childhood Rhabdomyosarcoma+2 more
Children's Oncology Group 99
Testing effectiveness (Phase 2)Study completedNCT00025441
What this trial is testing

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
Societe Internationale d'Oncologie Pediatrique
Not applicableStudy completedNCT01419509
What this trial is testing

DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 170
Large-scale testing (Phase 3)Study completedNCT00354835
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Botryoid-Type Embryonal Rhabdomyosarcoma+7 more
Children's Oncology Group 481
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Not applicableStudy completedNCT01668095
What this trial is testing

Biomarkers in Patients With Advanced Rhabdomyosarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal Rhabdomyosarcoma+5 more
Children's Oncology Group 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT00077285
What this trial is testing

Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 65
Not applicableWithdrawnNCT00334984
What this trial is testing

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
Children's Oncology Group
Load More Results